Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5

Journal of Cellular Physiology

Volumn 204, Issue 3, 2005, Pages 927-933

  Moro, Toru ^a   Ogasawara, Toru ^a   Chikuda, Hirotaka ^a   Ikeda, Toshiyuki ^a   Ogata, Naoshi ^a   Maruyama, Zenjiro ^b   Komori, Toshihisa ^b   Hoshi, Kazuto ^a   Chung, Ung Il ^a   Nakamura, Kozo ^b   Okayama, Hiroto ^a   Kawaguchi, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHONDROCYTES; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASES; DOWN-REGULATION; GENE EXPRESSION; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 23244460009     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20350     Document Type: Article

References (50)

1. Aikawa T, Segre GV, Lee K. 2001. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. J Biol Chem 276:29347-29352.
2. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7:812-821.
3. Beier F, Leask TA, Haque S, Chow C, Taylor AC, Lee RJ, Pestell RG, Ballock RT, LuValle P. 1999a. Cell cycle genes in chondrocyte proliferation and differentiation. Matrix Biol 18:109-120.
4. Beier F, Taylor AC, LuValle P. 1999b. The Raf-1/MEK/ERK pathway regulates the expression of the p21(Cip1/Waf1) gene in chondrocytes. J Biol Chem 274:30273-30279.
5. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. 1999. Sox9 is required for cartilage formation. Nat Genet 22:85-89.
6. Chellappan SP, Giordano A, Fisher PB. 1998. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr Top Microbiol Immunol 227:57-103.
7. Chen Q, Lin J, Jinno S, Okayama H. 2003. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation. Oncogene 22:992-1001.
8. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10:1633-1644.
9. Coqueret O. 2002. Linking cyclins to transcriptional control. Gene 299:35-55.
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
11. Erhardt JA, Pittman RN. 1998. Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J Biol Chem 273:23517-23523.
12. Grana X, Garriga J, Mayol X. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17:3365-3383.
13. Harper JW, Elledge SJ. 1996. Cdk inhibitors in development and cancer. Curr Opin Genet Dev 6:56-64.
14. Hengstschlager M, Braun K, Soucek T, Miloloza A, Hengstschlager-Ottnad E. 1999. Cyclin-dependent kinases at the G1-S transition of the mammalian cell cycle. Mutat Res 436:1-9.
15. Hidaka K, Kanematsu T, Takeuchi H, Nakata M, Kikkawa U, Hirata M. 2001. Involvement of the phosphoinositide 3-kinase/protein kinase B signaling pathway in insulin/IGF-I-induced chondrogenesis of the mouse embryonal carcinoma-derived cell line ATDC5. Int J Biochem Cell Biol 33:1094-1103.
16. Kadowaki T, Tobe K, Honda-Yamamoto R, Tamemoto H, Kaburagi Y, Momomura K, Ueki K, Takahashi Y, Yamauchi T, Akanuma Y, Yazaki Y. 1996. Signal transduction mechanism of insulin and insulin-like growth factor-1. Endocr J 43 (Suppl):S33-S41.
17. Karsenty G, Wagner EF. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406.
18. Lin J, Jinno S, Okayama H. 2001. Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence. Oncogene 20:2000-2009.
19. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP. 1996. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142-153.
20. LuValle P, Beier F. 2000. Cell cycle control in growth plate chondrocytes. Front Biosci 5:D493-D503.
21. MacLean HE, Guo J, Knight MC, Zhang P, Cobrinik D, Kronenberg HM. 2004. The cyclin-dependent kinase inhibitor p57(Kip2) mediates proliferative actions of PTHrP in chondrocytes. J Clin Invest 113:1334-1343.
22. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S, Dubus P, Barbacid M. 2004. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118:493-504.
23. Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y, Kanakura Y. 1997. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5. Mol Cell Biol 17:2933-2943.
24. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ. 1995. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662.
25. Matushansky I, Radparvar F, Skoultchi AI. 2003. CDK6 blocks differentiation: Coupling cell proliferation to the block to differentiation in leukemic cells. Oncogene 22:4143-4149.
26. Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C, Harlow E, Tsai LH. 1992. A family of human cdc2-related protein kinases. EMBO J 11:2909-2917.
27. Mundlos S, Olsen BR. 1997a. Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J 11:125-132.
28. Mundlos S, Olsen BR. 1997b. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis. FASEB J 11:227-233.
29. Nakajima M, Negishi Y, Tanaka H, Kawashima K. 2004. p21(Cip-1/SDI-1/WAF- 1) expression via the mitogen-activated protein kinase signaling pathway in insulin-induced chondrogenic differentiation of ATDC5 cells. Biochem Biophys Res Commun 320:1069-1075.
30. Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F. 1999. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp Cell Res 250:351-363.
31. Negishi Y, Ui N, Nakajima M, Kawashima K, Maruyama K, Takizawa T, Endo H. 2001. p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro. J Biol Chem 276:33249-33256.
32. Ogasawara T, Katagiri M, Yamamoto A, Hoshi K, Takato T, Nakamura K, Tanaka S, Okayama H, Kawaguchi H. 2004a. Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6). J Bone Miner Res 19:1128-1136.
33. Ogasawara T, Kawaguchi H, Jinno S, Hoshi K, Itaka K, Takato T, Nakamura K, Okayama H. 2004b. Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6. Mol Cell Biol 24:6560-6568.
34. Ohnuma S, Philpott A, Wang K, Holt CE, Harris WA. 1999. p27Xic1, a Cdk inhibitor, promotes the determination of glial cells in Xenopus retina. Cell 99:499-510.
35. Rossi F, MacLean HE, Yuan W, Francis RO, Semenova E, Lin CS, Kronenberg HM, Cobrinik D. 2002. p107 and p130 Coordinately regulate proliferation, Cbfa1 expression, and hypertrophic differentiation during endochondral bone development. Dev Biol 247:271-285.
36. Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF, Tobler A. 1995. Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest 95:973-979.
37. Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R, Moses HL. 1997. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541-552.
38. Sherr CJ. 1994. G1 phase progression: Cycling on cue. Cell 79:551-555.
39. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
40. Shukunami C, Shigeno C, Atsumi T, Ishizeki K, Suzuki F, Hiraki Y. 1996. Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: Differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J Cell Biol 133:457-468.
41. Shukunami C, Ohta Y, Sakuda M, Hiraki Y. 1998. Sequential progression of the differentiation program by bone morphogenetic protein-2 in chondrogenic cell line ATDC5. Exp Cell Res 241:1-11.
42. Smits P, Li P, Mandel J, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B, Lefebvre V. 2001. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1:277-290.
43. Steinman RA, Hoffman B. Iro A, Guillouf C, Liebermann DA, el-Houseini ME. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396.
44. Stewart MC, Kadlcek RM, Robbins PD, MacLeod JN, Ballock RT. 2004. Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation. J Bone Miner Res 19:123-132.
45. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. 1997. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390:184-187.
46. Tanaka K, Okayama H. 2000. A pcl-like cyclin activates the Res2p-Cdc10p cell cycle "start" transcriptional factor complex in fission yeast. Mol Biol Cell 11:2845-2862.
47. Urano T, Yashiroda H, Muraoka M, Tanaka K, Hosoi T, Inoue S, Ouchi Y, Toyoshima H. 1999. p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1. J Biol Chem 274:12197-12200.
48. Watanabe H, de Caestecker MP, Yamada Y. 2001. Transcriptional crosstalk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 276:14466-14473.
49. Yan Y, Frisen J, Lee MH, Massague J, Barbacid M. 1997. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 11:973-983.
50. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A. Harper JW, DePinho RA, Elledge SJ. 1997. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158.